Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial Meeting Abstract
| Authors: | Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; Oza, A. M.; González-Martín, A.; Aghajanian, C.; Bradley, W.; Lowe, E. S.; Bloomfield, R.; DiSilvestro, P. |
| Abstract Title: | Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy424.041 |
| Language: | English |
| ACCESSION: | WOS:000459277305017 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy424.041 |
| Notes: | Meeting Abstract: LBA7_PR -- Appears on page viii727 of the abstract book -- Source: Wos |
